Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kyle Sarnataro"'
Publikováno v:
Journal of Clinical Pathways. 4:27-30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fdb9fda23fe6f087fb1b73e1e9604a1
https://doi.org/10.25270/jcp.2018.05.00018
https://doi.org/10.25270/jcp.2018.05.00018
Autor:
Cristina Ruiz-Herguido, M. Carmen Lafita-Navarro, Rocío Aguado, Lucía García-Gutiérrez, Matilde Cañelles, Francisco Martin, Javier León, Eva Garcia-Alegria, Anna Bigas, Kyle Sarnataro
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Cancer Lett. 2016 May 28;375(1):92-9
UCrea Repositorio Abierto de la Universidad de Cantabria
instname
Cancer Lett. 2016 May 28;375(1):92-9
UCrea Repositorio Abierto de la Universidad de Cantabria
Chronic myeloid leukemia (CML) progresses from a chronic to a blastic phase, where the leukemic cells are proliferative and undifferentiated. The CML is nowadays successfully treated with BCR-ABL kinase inhibitors as imatinib and its derivatives. NUM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99aafa4733e68b1982edcf56dc7d003e
https://pubmed.ncbi.nlm.nih.gov/26944313
https://pubmed.ncbi.nlm.nih.gov/26944313
Autor:
D.W. Rosenthal, Artemio M. Jongco, Kyle Sarnataro, Jonathan D. Gough, Punita Ponda, Vincent R. Bonagura, Joanne Moreau
Pneumocystis jirovecii pneumonia is an opportunistic pulmonary infection usually associated with T-cell defects. Clinical and murine studies demonstrate that B-cells and Pneumocystis-specific antibodies also contribute to effective immune responses.1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::003800c42464acd29c4becfbafa9f69d
https://europepmc.org/articles/PMC3875599/
https://europepmc.org/articles/PMC3875599/
